Supplemental material
Journal of Medical Economics
Volume 24, 2021 - Issue 1
Cardiovascular Medicine
Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US population
, 
, , , , , & show all
François Lalibertéb Analysis Group, Inc, Montréal, QC, CanadaCorrespondence[email protected]
https://orcid.org/0000-0003-2601-6214
https://orcid.org/0000-0003-2601-6214, , Dominique Lejeuneb Analysis Group, Inc, Montréal, QC, Canadahttps://orcid.org/0000-0002-0981-0486
https://orcid.org/0000-0002-0981-0486, Kenneth Todd Moored Janssen Pharmaceuticals, Inc, Titusville, NJ, USAhttps://orcid.org/0000-0001-7505-102X
https://orcid.org/0000-0001-7505-102X, , & Veronica Ashtonc Janssen Scientific Affairs, LLC, Titusville, NJ, USAhttps://orcid.org/0000-0003-4880-1897
https://orcid.org/0000-0003-4880-1897 show all